You are here: Industry Insights > Market News > Bharat Biotech signs supply deal with Brazil for 20 million doses of COVAXIN

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate

Neohesperidin

Advantame

Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench

Pharma and Food Grade, USP/FCC Neotame Sweetener E961

Trilobatin

Bharat Biotech signs supply deal with Brazil for 20 million doses of COVAXIN

expresspharmaMarch 01, 2021

Tag: Bharat Biotech , brazil , Covaxin

Favorites

Bharat Biotech International confirmed that the company has signed an agreement with Brazil for supply of 20 million doses of COVAXIN.

It has signed an agreement for the delivery of COVAXIN during Q2 and Q3 2021.

The company informed through a statement, “The company is delighted to partner with Brazil in its battle against Covid-19 and aid its immunization program against the virus. There is a strong interest in COVAXIN from many countries around the world, and the company is fully committed to ensuring supplies promptly and efficiently.”

Previous:Sales of injectable anti-HIV therapeutics will reach $2 billion in 2029: GlobalData

Next:NATCO launches Brivaracetam tablets in India

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Bharat Biotech signs supply deal with Brazil for 20 million doses of COVAXIN | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

Bharat Biotech signs supply deal with Brazil for 20 million doses of COVAXIN

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may like
More>>

Bharat Biotech signs supply deal with Brazil for 20 million doses of COVAXIN

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may likeMore>>

You may like
More>>